News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Brittany Parker Kerrigan: Honored to have contributed 2M to MD Anderson Cancer Center’s team in their quest for a cure for brain cancer
Photo from Brittany Parker Kerrigan/LinkedIn
Jul 22, 2024, 22:14

Brittany Parker Kerrigan: Honored to have contributed 2M to MD Anderson Cancer Center’s team in their quest for a cure for brain cancer

Brittany Parker Kerrigan, Chief Operating Officer at Lindonlight Collective, shared a post on LinkedIn:

”Very honored to have contributed 2M to MD Anderson Cancer Center‘s Michael Curran, Federica Pericle and the entire ImmunoGenesis team in their quest for a cure for brain cancer.

More on their exciting research can be found here.”

Source: Brittany Parker Kerrigan/LinkedIn

brain cancer Brittany Parker Kerrigan cancer Cancer research Federica Pericle ImmunoGenesis Lindonlight Collective MD Anderson Cancer Center Michael Curran OncoDaily Oncology
Special Coverage
Blog
Nov 13, 2024, 11:39
i4KIDS I i4KIDS-EUROPE - Ship2B Ventures Impact Forum
Blog
Nov 13, 2024, 11:34
Erika Hamilton: Inspired by the strength of the veteran patients and their commitment to continue fighting
Blog
Nov 13, 2024, 11:30
ABC Global Alliance - Learning more about brain metastases in breast cancer
Blog
Nov 13, 2024, 11:25
Some information you should know about lung cancer - American Cancer Society
Insight
Nov 13, 2024, 11:10
Myeloma Paper of the Day, November 13th, suggested by Robert Orlowski
Blog
Nov 13, 2024, 11:01
LGCW2024 session on Galvanising African cancer research building a strong cancer workforce - AORTIC- Africa
Blog
Nov 13, 2024, 10:59
Bernard Fox received SITC lifetime achievement award
Blog
Nov 13, 2024, 10:54
Hear Her campaign Increasing awareness about lung cancer in women
Blog
Nov 13, 2024, 10:52
Johnson & Johnson Seeks Approval for DARZALEX FASPRO as Subcutaneous Monotherapy for High-Risk Smoldering Multiple Myeloma
Blog
Nov 13, 2024, 10:47
FDA approves obecabtagene autoleucel for relapsed or refractory B-cell precursor ALL
Blog
Nov 13, 2024, 10:45
OncoInfluencers to Follow on Social Media: Dr. Nitin Jain
Insight
Nov 13, 2024, 10:37
UCLA: Combination approach shows promise for treating rare, aggressive cancers